A quiet but revolutionary milestone may be unfolding in Indian pharmaceutical history—one that could redefine the country’s global positioning not just as a manufacturer of generics but as a birthplace of cutting-edge innovation. The spark? A first-in-class antibiotic from Wockhardt, called Zaynich (WCK 5222).
What Makes Zaynich Different?
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
